pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 2
moxidectin
Moxidectin
Scabies
Atticus Medical Pty Ltd
Marketed
moxifloxacin
Moxifloxacin (moxifloxacin [INN])
Bacterial Conjunctivitis
Fosun Pharma USA Inc
Phase 2
mozistobart zoratolimod
mozistobart zoratolimod [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Tallac Therapeutics Inc
Phase 2
← prev
page 197 of 231
next →
Pain
89
Neurology
1
mupadolimab
mupadolimab
Non-Small Cell Lung Cancer
$CRVS
Corvus Pharmaceuticals, Inc.
Marketed
mupirocin calcium
Mupirocin Calcium
Impetigo
Amneal Pharmaceuticals of New York LLC
Phase 2
muzastotug
muzastotug [INN]
Solid Tumor
$ADAG
Adagene Inc.
Marketed
mycophenolate mofetil hydrochloride
Mycophenolate Mofetil Hydrochloride
Heart Transplant Rejection
Meitheal Pharmaceuticals Inc
Marketed
mycophenolic acid DR
Mycophenolic Acid
Kidney Transplant Rejection
TWi Pharmaceuticals USA Inc
Phase 2
nLLMNB1-001
Leukodystrophies
n-Lorem Foundation
Phase 2
nLTUBB4-001
Leukodystrophies
n-Lorem Foundation
Phase 1
nabatrinols
nabatrinols
Complex Regional Pain Syndrome (Sympathetic Reflex Dystro…
$RILY
BRC Group Holdings, Inc.
Preclinical
nabilone
nabilone
Glaucoma
Adtech Pharma Inc
Marketed
nabumetone
Nabumetone
Osteoarthritis Pain
Nexgen Pharma Inc
Marketed
nadofaragene firadenovec
Adstiladrin (nadofaragene firadenovec)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
Ferring Pharmaceuticals Inc
Marketed
nadolol
Nadolol
Angina (Angina Pectoris)
Beximco Pharmaceuticals USA Inc
Phase 3
nadunolimab
nadunolimab [INN]
Pancreatic Ductal Adenocarcinoma
Cantargia AB
Phase 1
nafamostat mesylate
nafamostat mesylate
Coronavirus Disease 2019 (COVID-19)
$ENSC
Ensysce Biosciences, Inc.
Marketed
nafcillin sodium
Nafcillin Sodium
Bacterial Endocarditis
Claris Lifesciences Inc
Marketed
naftifine hydrochloride
Naftin (naftifine hydrochloride)
Tinea Corporis
Legacy Pharma Solutions
Marketed
naldemedine tosylate
Symproic (naldemedine tosylate)
Opioid-Induced Constipation (OIC)
BioDelivery Sciences International Inc
Marketed
naloxegol oxalate
Movantik (naloxegol oxalate)
Opioid-Induced Constipation (OIC)
Grunenthal USA Inc
Phase 1
naloxone
naloxone [INN]
Acute Opioid Overdosage
Taho Pharmaceuticals Ltd
Marketed
naltrexone hydrochloride
Lodonal (naltrexone hydrochloride)
Autoimmune Hepatitis
Biostax Corp
Phase 3
namodenoson
namodenoson
Hepatocellular Carcinoma
$CANF
Can-Fite BioPharma Ltd.
Preclinical
nanoencorafenib
Colorectal Cancer
Nanoform Finland Plc
Phase 3
nanvuranlat
nanvuranlat [INN]
Metastatic Biliary Tract Cancer
J-Pharma Co Ltd
Phase 3
napazimone
napazimone
Mitochondrial Diseases
Abliva AB
Preclinical
naproxcinod
naproxcinod
Sickle Cell Disease With Vaso-Occlusive Crisis
Fera Pharmaceuticals LLC
Marketed
naratriptan hydrochloride
Naratriptan (naratriptan hydrochloride)
Migraine
Orchid Pharma Inc
Phase 2
narmafotinib tartrate
narmafotinib tartrate
Metastatic Adenocarcinoma of The Pancreas
Amplia Therapeutics Ltd